Evidence map›Paper›PMID 30307962›Full record

ArticlePloS one2018

Screening of herbal extracts for TLR2- and TLR4-dependent anti-inflammatory effects.

Anne Schink, Jan Neumann, Anna Lena Leifke, Kira Ziegler, Janine Fröhlich-Nowoisky, Christoph Cremer, Eckhard Thines, Bettina Weber, Ulrich Pöschl, Detlef Schuppan and 1 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in pharmacology · 2024
    Article
  8. Nutrients · 2023
    Article
  9. Molecules (Basel, Switzerland) · 2023
    Review
  10. Review
  11. Molecules (Basel, Switzerland) · 2022
    Article
  12. Anti-Inflammatory Activity of Bilberry (Current issues in molecular biology · 2022
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Anne SchinkMultiphase Chemistry Department, Max Planck Institute for Chemistry, Mainz, Germany.
Jan NeumannMultiphase Chemistry Department, Max Planck Institute for Chemistry, Mainz, Germany.
Anna Lena LeifkeMultiphase Chemistry Department, Max Planck Institute for Chemistry, Mainz, Germany.
Kira ZieglerMultiphase Chemistry Department, Max Planck Institute for Chemistry, Mainz, Germany.
Janine Fröhlich-NowoiskyMultiphase Chemistry Department, Max Planck Institute for Chemistry, Mainz, Germany.
Christoph CremerMultiphase Chemistry Department, Max Planck Institute for Chemistry, Mainz, Germany.
Eckhard ThinesInstitut für Biotechnologie und Wirkstoff-Forschung gGmbH, Kaiserslautern, Germany.
Bettina WeberMultiphase Chemistry Department, Max Planck Institute for Chemistry, Mainz, Germany.
Ulrich PöschlMultiphase Chemistry Department, Max Planck Institute for Chemistry, Mainz, Germany.
Detlef SchuppanInstitute of Translational Immunology, University of Mainz Medical Center, Mainz, Germany.
Kurt LucasMultiphase Chemistry Department, Max Planck Institute for Chemistry, Mainz, Germany.ORCID 0000-0001-8267-7397
Max Planck Institute for Chemistry · DEBeth Israel Deaconess Medical Center · USJohannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herbal extracts represent an ample source of natural compounds, with potential to be used in improving human health. There is a growing interest in using natural extracts as possible new treatment strategies for inflammatory diseases. We therefore aimed at identifying herbal extracts that affect inflammatory signaling pathways through toll-like receptors (TLRs), TLR2 and TLR4. Ninety-nine ethanolic extracts were screened in THP-1 monocytes and HeLa-TLR4 transfected reporter cells for their effects on stimulated TLR2 and TLR4 signaling pathways. The 28 identified anti-inflammatory extracts were tested in comparative assays of stimulated HEK-TLR2 and HEK-TLR4 transfected reporter cells to differentiate between direct TLR4 antagonistic effects and interference with downstream signaling cascades. Furthermore, the ten most effective anti-inflammatory extracts were tested on their ability to inhibit nuclear factor-κB (NF-κB) translocation in HeLa-TLR4 transfected reporter cell lines and for their ability to repolarize M1-type macrophages. Ethanolic extracts which showed the highest anti-inflammatory potential, up to a complete inhibition of pro-inflammatory cytokine production were Castanea sativa leaves, Cinchona pubescens bark, Cinnamomum verum bark, Salix alba bark, Rheum palmatum root, Alchemilla vulgaris plant, Humulus lupulus cones, Vaccinium myrtillus berries, Curcuma longa root and Arctostaphylos uva-ursi leaves. Moreover, all tested extracts mitigated not only TLR4, but also TLR2 signaling pathways. Seven of them additionally inhibited translocation of NF-κB into the nucleus. Two of the extracts showed impact on repolarization of pro-inflammatory M1-type to anti-inflammatory M2-type macrophages. Several promising anti-inflammatory herbal extracts were identified in this study, including extracts with previously unknown influence on key TLR signaling pathways and macrophage repolarization, serving as a basis for novel lead compound identification.

Indexed as

Anti-Inflammatory AgentsDrug Evaluation, PreclinicalGene Expression RegulationHEK293 CellsHeLa CellsHumansPlant BarkPlant ExtractsPlant LeavesPlant RootsTHP-1 CellsToll-Like Receptor 2Toll-Like Receptor 4TransfectionAnti-Inflammatory AgentsPlant ExtractsTLR2 protein, humanTLR4 protein, humanToll-Like Receptor 2Toll-Like Receptor 4

Identifiers

PMID30307962
PMCPMC6181297
OpenAlexW2897434733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.